Free Trial

UK Body Confirms AZ Jab As Safe, EMA Presents At 1600CET

GLOBAL POLITICAL RISK

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that the AstraZeneca/Oxford University vaccine should continue to be administered following the halt of rollout in a number of European countries.

  • Link: https://www.gov.uk/government/news/uk-regulator-co...
  • "A further, detailed review into five UK reports of a very rare and specific type of blood clot [...] is ongoing. This has been reported in less than 1 in a million people vaccinated so far in the UK, and can also occur naturally – a causal association with the vaccine has not been established."
  • MHRA comment comes as EMA gets ready to present its findings from an investigation into potential clotting issues related to the AZ jab. Presentation due to take place at 1600CET (1100ET, 1500GMT).
  • Link: https://www.ema.europa.eu/en/events/press-briefing...

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.